Tetraethylammonium Trifluoromethanesulfonate is a biochemical compound that may be utilized as a biomaterial or organic/chemical reagent for biomedical research.

Physicochemical Properties

Molecular Formula	C9H20F3NO3S
Molecular Weight	279.32
Exact Mass	279.111
CAS #	35895-69-3
PubChem CID	2776566
Appearance	White to off-white solid powder
Melting Point	161-163 °C
LogP	3.015
Hydrogen Bond Donor Count	0
Hydrogen Bond Acceptor Count	6
Rotatable Bond Count	4
Heavy Atom Count	17
Complexity	192
Defined Atom Stereocenter Count	0
InChi Key	PUZYNDBTWXJXKN-UHFFFAOYSA-M
InChi Code	InChI=1S/C8H20N.CHF3O3S/c1-5-9(6-2,7-3)8-4;2-1(3,4)8(5,6)7/h5-8H2,1-4H3;(H,5,6,7)/q+1;/p-1
Chemical Name	tetraethylazanium;trifluoromethanesulfonate
Synonyms	35895-69-3; Tetraethylammonium trifluoromethanesulfonate; Tetraethylammonium trifluoromethanesulphonate; Tetraethylammonium Triflate; TETRAETHYLAMMONIUMTRIFLUOROMETHANESULFONATE; tetraethylazanium;trifluoromethanesulfonate; MFCD00042586; tetraethylazanium trifluoromethanesulfonate;
HS Tariff Code	2934.99.9001
Storage	Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture.
Shipping Condition	Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity

Targets	Phase transfer catalyst
ln Vitro	In this report, the electrical performance at T > 100 degrees C and low relative humidity of proton-conducting Nafion-based membranes was improved by preparing new materials based on Nafion 117 (N117) neutralized with triethylammonium (TEA(+)) and doped with the ionic liquid (IL) trifluoromethanesulfonate of triethylammonium (TEA-TF). In particular, a new two-step protocol for the preparation of [N117(x-)(TEA(+))(x)/(TEA-TF)(y)] is proposed. [N117(x-)(TEA(+))(x)/(TEA-TF)(y)] membrane is composed of ca. 30 wt % of TEA-TF. The structure of the different nanophases composing the materials and their interactions were investigated by FT-IR ATR and micro-Raman spectroscopy. The thermal stability, water uptake, and mechanical properties of the membranes were studied by thermogravimetric analysis and dynamic mechanical analysis measurements. With respect to pristine N117, the thermal and mechanical properties of the proposed materials were improved. The electric response of [N117(x-)(TEA(+))(x)/(TEA-TF)(y)] was studied by broad band dielectric spectroscopy in the frequency range from 10(-2) Hz to 10 MHz and for temperatures between 5 and 155 degrees C. In comparison to the N117 reference, the following was observed: (a) the stability range of conductivity (SRC) of the [N117(x-)(TEA(+))(x)] membrane increases up to 155 degrees C, while its sigma(DC) at T = 100 degrees C is lowered by ca. 2 orders of magnitude; (b) the SRC of [N117(x-)(TEA(+))(x)/(TEA-TF)(y)] is similar to that of [N117(x-)(TEA(+))(x)], while the sigma(DC) at 145 degrees C decreases in the order 7.3 x 10(-3) > 6.1 x 10(-3) > 9.7 x 10(-4) S x cm(-1) for [N117(x-)(TEA(+))(x)/(TEA-TF)(y)], N117, and [N117(x-)(TEA(+))(x)] membranes, respectively. In conclusion, the lower water uptake, the improved thermal and mechanical stability, and the good conductivity make [N117(x-)(TEA(+))(x)/(TEA-TF)(y)] a promising membrane to improve for application in proton exchange membrane fuel cells operating under anhydrous conditions at T > 100 degrees C.[1]
References	[1]. Structure-relaxation interplay of a new nanostructured membrane based on tetraethylammonium trifluoromethanesulfonate ionic liquid and neutralized nafion 117 for high-temperature fuel cells. J Am Chem Soc . 2010 Feb 24;132(7):2183-95.

Solubility Data

Solubility (In Vitro)

May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples

Solubility (In Vivo)

Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples. Injection Formulations (e.g. IP/IV/IM/SC) Injection Formulation 1: DMSO : Tween 80： Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 ：Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] *Preparation of 20% SBE-β-CD in Saline (4°C，1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Injection Formulation 5: 2-Hydroxypropyl-β-cyclodextrin : Saline = 50 : 50 (i.e. 500 μL 2-Hydroxypropyl-β-cyclodextrin → 500 μL Saline) Injection Formulation 6: DMSO : PEG300 : castor oil : Saline = 5 : 10 : 20 : 65 (i.e. 50 μL DMSO → 100 μLPEG300 → 200 μL castor oil → 650 μL Saline) Injection Formulation 7: Ethanol : Cremophor : Saline = 10： 10 : 80 (i.e. 100 μL Ethanol → 100 μL Cremophor → 800 μL Saline) Injection Formulation 8: Dissolve in Cremophor/Ethanol (50 : 50), then diluted by Saline Injection Formulation 9: EtOH : Corn oil = 10 : 90 (i.e. 100 μL EtOH → 900 μL Corn oil) Injection Formulation 10: EtOH : PEG300：Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL EtOH → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Oral Formulations Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). Oral Formulation 3: Dissolved in PEG400 Oral Formulation 4: Suspend in 0.2% Carboxymethyl cellulose Oral Formulation 5: Dissolve in 0.25% Tween 80 and 0.5% Carboxymethyl cellulose Oral Formulation 6: Mixing with food powders Note: Please be aware that the above formulations are for reference only. InvivoChem strongly recommends customers to read literature methods/protocols carefully before determining which formulation you should use for in vivo studies, as different compounds have different solubility properties and have to be formulated differently.  (Please use freshly prepared in vivo formulations for optimal results.)

Preparing Stock Solutions		1 mg	5 mg	10 mg
	1 mM	3.5801 mL	17.9006 mL	35.8012 mL
	5 mM	0.7160 mL	3.5801 mL	7.1602 mL
	10 mM	0.3580 mL	1.7901 mL	3.5801 mL

*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.